North America Oral Vaccines Market by Manufacturers, Countries, Type and Application, Forecast to 2022
An oral vaccine is one that is taken by mouth, instead of being injected directly into the blood. The goal of all vaccines, whether administered by injection or as an oral vaccine, is to trigger the body’s immune system without the person actually having the disease. It is a way of immunizing, or protecting, the body from getting the disease.
Scope of the Report:
This report focuses on the Oral Vaccines in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.
Market Segment by Manufacturers, this report covers
Chapter 1, to describe Oral Vaccines Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;
Chapter 2, to analyze the manufacturers of Oral Vaccines, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Oral Vaccines, for each country, from 2012 to 2017;
Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;
Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;
Chapter 10, Oral Vaccines market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;
Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.
Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);
Chapter 13, to describe sales channel, distributors, traders, dealers etc.
Chapter 14 and 15, to describe Oral Vaccines Research Findings and Conclusion, Appendix, methodology and data source
Scope of the Report:
This report focuses on the Oral Vaccines in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.
Market Segment by Manufacturers, this report covers
- GlaxoSmithKline
- PaxVax
- Merial
- Merck
- Sanofi
- Crucell
- Quimica Suiza
- Immunitor
- Hualan Biological Engineering
- Serum Institute of India
- BB-NCIPD
- Vaxart
- United States
- Canada
- Mexico
- Rotavirus Vaccine
- Cholera Vaccine
- Polio Vaccine
- Others
- Infant
- Children
- Adults
Chapter 1, to describe Oral Vaccines Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;
Chapter 2, to analyze the manufacturers of Oral Vaccines, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Oral Vaccines, for each country, from 2012 to 2017;
Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;
Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;
Chapter 10, Oral Vaccines market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;
Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.
Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);
Chapter 13, to describe sales channel, distributors, traders, dealers etc.
Chapter 14 and 15, to describe Oral Vaccines Research Findings and Conclusion, Appendix, methodology and data source
1 MARKET OVERVIEW
1.1 Oral Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Rotavirus Vaccine
1.2.2 Cholera Vaccine
1.2.3 Polio Vaccine
1.2.4 Others
1.3 Market Analysis by Applications
1.3.1 Infant
1.3.2 Children
1.3.3 Adults
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 Mexico Status and Prospect (2012-2022)
1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 GlaxoSmithKline
2.1.1 Profile
2.1.2 Oral Vaccines Type and Applications
2.1.2.1 Type
2.1.2.2 Type
2.1.3 GlaxoSmithKline Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 GlaxoSmithKline News
2.2 PaxVax
2.2.1 Profile
2.2.2 Oral Vaccines Type and Applications
2.2.2.1 Type
2.2.2.2 Type
2.2.3 PaxVax Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 PaxVax News
2.3 Merial
2.3.1 Profile
2.3.2 Oral Vaccines Type and Applications
2.3.2.1 Type
2.3.2.2 Type
2.3.3 Merial Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 Merial News
2.4 Merck
2.4.1 Profile
2.4.2 Oral Vaccines Type and Applications
2.4.2.1 Type
2.4.2.2 Type
2.4.3 Merck Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 Merck News
2.5 Sanofi
2.5.1 Profile
2.5.2 Oral Vaccines Type and Applications
2.5.2.1 Type
2.5.2.2 Type
2.5.3 Sanofi Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 Sanofi News
2.6 Crucell
2.6.1 Profile
2.6.2 Oral Vaccines Type and Applications
2.6.2.1 Type
2.6.2.2 Type
2.6.3 Crucell Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.4 Business Overview
2.6.5 Crucell News
2.7 Quimica Suiza
2.7.1 Profile
2.7.2 Oral Vaccines Type and Applications
2.7.2.1 Type
2.7.2.2 Type
2.7.3 Quimica Suiza Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.4 Business Overview
2.7.5 Quimica Suiza News
2.8 Immunitor
2.8.1 Profile
2.8.2 Oral Vaccines Type and Applications
2.8.2.1 Type
2.8.2.2 Type
2.8.3 Immunitor Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.4 Business Overview
2.8.5 Immunitor News
2.9 Hualan Biological Engineering
2.9.1 Profile
2.9.2 Oral Vaccines Type and Applications
2.9.2.1 Type
2.9.2.2 Type
2.9.3 Hualan Biological Engineering Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.4 Business Overview
2.9.5 Hualan Biological Engineering News
2.10 Serum Institute of India
2.10.1 Profile
2.10.2 Oral Vaccines Type and Applications
2.10.2.1 Type
2.10.2.2 Type
2.10.3 Serum Institute of India Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.4 Business Overview
2.10.5 Serum Institute of India News
2.11 BB-NCIPD
2.11.1 Profile
2.11.2 Oral Vaccines Type and Applications
2.11.2.1 Type
2.11.2.2 Type
2.11.3 BB-NCIPD Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11.4 Business Overview
2.11.5 BB-NCIPD News
2.12 Vaxart
2.12.1 Profile
2.12.2 Oral Vaccines Type and Applications
2.12.2.1 Type
2.12.2.2 Type
2.12.3 Vaxart Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12.4 Business Overview
2.12.5 Vaxart News
3 NORTH AMERICA ORAL VACCINES MARKET COMPETITION, BY MANUFACTURER
3.1 North America Oral Vaccines Sales and Market Share by Manufacturer (2016-2017)
3.2 North America Oral Vaccines Revenue and Market Share by Manufacturer (2016-2017)
3.3 North America Oral Vaccines Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Oral Vaccines Manufacturer Market Share
3.4.2 Top 5 Oral Vaccines Manufacturer Market Share
3.5 Market Competition Trend
4 NORTH AMERICA ORAL VACCINES MARKET ANALYSIS BY COUNTRIES
4.1 North America Oral Vaccines Sales Market Share by Countries
4.2 North America Oral Vaccines Sales by Countries (2012-2017)
4.3 North America Oral Vaccines Revenue (Value) by Countries (2012-2017)
5 NORTH AMERICA MARKET SEGMENTATION ORAL VACCINES BY TYPE
5.1 North America Oral Vaccines Sales, Revenue and Market Share by Type (2012-2017)
5.1.1 North America Oral Vaccines Sales and Market Share by Type (2012-2017)
5.1.2 North America Oral Vaccines Revenue and Market Share by Type (2012-2017)
5.2 Rotavirus Vaccine Sales Growth and Price
5.2.1 North America Rotavirus Vaccine Sales Growth (2012-2017)
5.2.2 North America Rotavirus Vaccine Price (2012-2017)
5.3 Cholera Vaccine Sales Growth and Price
5.3.1 North America Cholera Vaccine Sales Growth (2012-2017)
5.3.2 North America Cholera Vaccine Price (2012-2017)
5.4 Polio Vaccine Sales Growth and Price
5.4.1 North America Polio Vaccine Sales Growth (2012-2017)
5.4.2 North America Polio Vaccine Price (2012-2017)
5.5 Others Sales Growth and Price
5.5.1 North America Others Sales Growth (2012-2017)
5.5.2 North America Others Price (2012-2017)
6 NORTH AMERICA MARKET SEGMENTATION ORAL VACCINES BY APPLICATION
6.1 North America Oral Vaccines Sales Market Share by Application (2012-2017)
6.2 Infant Sales Growth (2012-2017)
6.3 Children Sales Growth (2012-2017)
6.4 Adults Sales Growth (2012-2017)
7 UNITED STATES ORAL VACCINES SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
7.1 United States Oral Vaccines Revenue, Sales and Growth Rate (2012-2017)
7.2 United States Oral Vaccines Sales and Market Share by Type
7.3 United States Oral Vaccines Sales by Application (2012-2017)
7.4 United States Oral Vaccines Sales, Revenue and Market Share by Manufacturer
7.4.1 United States Oral Vaccines Sales and Market Share by Manufacturer
7.4.2 United States Oral Vaccines Revenue and Market Share by Manufacturer
7.5 United States Oral Vaccines Export and Import (2012-2017)
8 CANADA ORAL VACCINES SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
8.1 Canada Oral Vaccines Revenue, Sales and Growth Rate (2012-2017)
8.2 Canada Oral Vaccines Sales and Market Share by Type
8.3 Canada Oral Vaccines Sales by Application (2012-2017)
8.4 Canada Oral Vaccines Sales, Revenue and Market Share by Manufacturer
8.4.1 Canada Oral Vaccines Sales and Market Share by Manufacturer
8.4.2 Canada Oral Vaccines Revenue and Market Share by Manufacturer
8.5 Canada Oral Vaccines Export and Import (2012-2017)
9 MEXICO ORAL VACCINES SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
9.1 Mexico Oral Vaccines Revenue, Sales and Growth Rate (2012-2017)
9.2 Mexico Oral Vaccines Sales and Market Share by Type
9.3 Mexico Oral Vaccines Sales by Application (2012-2017)
9.4 Mexico Oral Vaccines Sales, Revenue and Market Share by Manufacturer
9.4.1 Mexico Oral Vaccines Sales and Market Share by Manufacturer
9.4.2 Mexico Oral Vaccines Revenue and Market Share by Manufacturer
9.5 Mexico Oral Vaccines Export and Import (2012-2017)
10 ORAL VACCINES MARKET FORECAST (2017-2022)
10.1 North America Oral Vaccines Sales, Revenue and Growth Rate (2017-2022)
10.2 Oral Vaccines Market Forecast by Countries (2017-2022)
10.2.1 United States Oral Vaccines Forecast (2017-2022)
10.2.2 Canada Oral Vaccines Forecast (2017-2022)
10.2.3 Mexico Oral Vaccines Forecast (2017-2022)
10.3 Oral Vaccines Market Forecast by Type (2017-2022)
10.4 Oral Vaccines Market Forecast by Application (2017-2022)
11 ORAL VACCINES MANUFACTURING COST ANALYSIS
11.1 Oral Vaccines Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Oral Vaccines
12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
12.1 Oral Vaccines Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Oral Vaccines Major Manufacturers in 2016
12.4 Downstream Buyers
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source
1.1 Oral Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Rotavirus Vaccine
1.2.2 Cholera Vaccine
1.2.3 Polio Vaccine
1.2.4 Others
1.3 Market Analysis by Applications
1.3.1 Infant
1.3.2 Children
1.3.3 Adults
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 Mexico Status and Prospect (2012-2022)
1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 GlaxoSmithKline
2.1.1 Profile
2.1.2 Oral Vaccines Type and Applications
2.1.2.1 Type
2.1.2.2 Type
2.1.3 GlaxoSmithKline Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 GlaxoSmithKline News
2.2 PaxVax
2.2.1 Profile
2.2.2 Oral Vaccines Type and Applications
2.2.2.1 Type
2.2.2.2 Type
2.2.3 PaxVax Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 PaxVax News
2.3 Merial
2.3.1 Profile
2.3.2 Oral Vaccines Type and Applications
2.3.2.1 Type
2.3.2.2 Type
2.3.3 Merial Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 Merial News
2.4 Merck
2.4.1 Profile
2.4.2 Oral Vaccines Type and Applications
2.4.2.1 Type
2.4.2.2 Type
2.4.3 Merck Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 Merck News
2.5 Sanofi
2.5.1 Profile
2.5.2 Oral Vaccines Type and Applications
2.5.2.1 Type
2.5.2.2 Type
2.5.3 Sanofi Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 Sanofi News
2.6 Crucell
2.6.1 Profile
2.6.2 Oral Vaccines Type and Applications
2.6.2.1 Type
2.6.2.2 Type
2.6.3 Crucell Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.4 Business Overview
2.6.5 Crucell News
2.7 Quimica Suiza
2.7.1 Profile
2.7.2 Oral Vaccines Type and Applications
2.7.2.1 Type
2.7.2.2 Type
2.7.3 Quimica Suiza Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.4 Business Overview
2.7.5 Quimica Suiza News
2.8 Immunitor
2.8.1 Profile
2.8.2 Oral Vaccines Type and Applications
2.8.2.1 Type
2.8.2.2 Type
2.8.3 Immunitor Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.4 Business Overview
2.8.5 Immunitor News
2.9 Hualan Biological Engineering
2.9.1 Profile
2.9.2 Oral Vaccines Type and Applications
2.9.2.1 Type
2.9.2.2 Type
2.9.3 Hualan Biological Engineering Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.4 Business Overview
2.9.5 Hualan Biological Engineering News
2.10 Serum Institute of India
2.10.1 Profile
2.10.2 Oral Vaccines Type and Applications
2.10.2.1 Type
2.10.2.2 Type
2.10.3 Serum Institute of India Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.4 Business Overview
2.10.5 Serum Institute of India News
2.11 BB-NCIPD
2.11.1 Profile
2.11.2 Oral Vaccines Type and Applications
2.11.2.1 Type
2.11.2.2 Type
2.11.3 BB-NCIPD Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11.4 Business Overview
2.11.5 BB-NCIPD News
2.12 Vaxart
2.12.1 Profile
2.12.2 Oral Vaccines Type and Applications
2.12.2.1 Type
2.12.2.2 Type
2.12.3 Vaxart Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12.4 Business Overview
2.12.5 Vaxart News
3 NORTH AMERICA ORAL VACCINES MARKET COMPETITION, BY MANUFACTURER
3.1 North America Oral Vaccines Sales and Market Share by Manufacturer (2016-2017)
3.2 North America Oral Vaccines Revenue and Market Share by Manufacturer (2016-2017)
3.3 North America Oral Vaccines Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Oral Vaccines Manufacturer Market Share
3.4.2 Top 5 Oral Vaccines Manufacturer Market Share
3.5 Market Competition Trend
4 NORTH AMERICA ORAL VACCINES MARKET ANALYSIS BY COUNTRIES
4.1 North America Oral Vaccines Sales Market Share by Countries
4.2 North America Oral Vaccines Sales by Countries (2012-2017)
4.3 North America Oral Vaccines Revenue (Value) by Countries (2012-2017)
5 NORTH AMERICA MARKET SEGMENTATION ORAL VACCINES BY TYPE
5.1 North America Oral Vaccines Sales, Revenue and Market Share by Type (2012-2017)
5.1.1 North America Oral Vaccines Sales and Market Share by Type (2012-2017)
5.1.2 North America Oral Vaccines Revenue and Market Share by Type (2012-2017)
5.2 Rotavirus Vaccine Sales Growth and Price
5.2.1 North America Rotavirus Vaccine Sales Growth (2012-2017)
5.2.2 North America Rotavirus Vaccine Price (2012-2017)
5.3 Cholera Vaccine Sales Growth and Price
5.3.1 North America Cholera Vaccine Sales Growth (2012-2017)
5.3.2 North America Cholera Vaccine Price (2012-2017)
5.4 Polio Vaccine Sales Growth and Price
5.4.1 North America Polio Vaccine Sales Growth (2012-2017)
5.4.2 North America Polio Vaccine Price (2012-2017)
5.5 Others Sales Growth and Price
5.5.1 North America Others Sales Growth (2012-2017)
5.5.2 North America Others Price (2012-2017)
6 NORTH AMERICA MARKET SEGMENTATION ORAL VACCINES BY APPLICATION
6.1 North America Oral Vaccines Sales Market Share by Application (2012-2017)
6.2 Infant Sales Growth (2012-2017)
6.3 Children Sales Growth (2012-2017)
6.4 Adults Sales Growth (2012-2017)
7 UNITED STATES ORAL VACCINES SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
7.1 United States Oral Vaccines Revenue, Sales and Growth Rate (2012-2017)
7.2 United States Oral Vaccines Sales and Market Share by Type
7.3 United States Oral Vaccines Sales by Application (2012-2017)
7.4 United States Oral Vaccines Sales, Revenue and Market Share by Manufacturer
7.4.1 United States Oral Vaccines Sales and Market Share by Manufacturer
7.4.2 United States Oral Vaccines Revenue and Market Share by Manufacturer
7.5 United States Oral Vaccines Export and Import (2012-2017)
8 CANADA ORAL VACCINES SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
8.1 Canada Oral Vaccines Revenue, Sales and Growth Rate (2012-2017)
8.2 Canada Oral Vaccines Sales and Market Share by Type
8.3 Canada Oral Vaccines Sales by Application (2012-2017)
8.4 Canada Oral Vaccines Sales, Revenue and Market Share by Manufacturer
8.4.1 Canada Oral Vaccines Sales and Market Share by Manufacturer
8.4.2 Canada Oral Vaccines Revenue and Market Share by Manufacturer
8.5 Canada Oral Vaccines Export and Import (2012-2017)
9 MEXICO ORAL VACCINES SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
9.1 Mexico Oral Vaccines Revenue, Sales and Growth Rate (2012-2017)
9.2 Mexico Oral Vaccines Sales and Market Share by Type
9.3 Mexico Oral Vaccines Sales by Application (2012-2017)
9.4 Mexico Oral Vaccines Sales, Revenue and Market Share by Manufacturer
9.4.1 Mexico Oral Vaccines Sales and Market Share by Manufacturer
9.4.2 Mexico Oral Vaccines Revenue and Market Share by Manufacturer
9.5 Mexico Oral Vaccines Export and Import (2012-2017)
10 ORAL VACCINES MARKET FORECAST (2017-2022)
10.1 North America Oral Vaccines Sales, Revenue and Growth Rate (2017-2022)
10.2 Oral Vaccines Market Forecast by Countries (2017-2022)
10.2.1 United States Oral Vaccines Forecast (2017-2022)
10.2.2 Canada Oral Vaccines Forecast (2017-2022)
10.2.3 Mexico Oral Vaccines Forecast (2017-2022)
10.3 Oral Vaccines Market Forecast by Type (2017-2022)
10.4 Oral Vaccines Market Forecast by Application (2017-2022)
11 ORAL VACCINES MANUFACTURING COST ANALYSIS
11.1 Oral Vaccines Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Oral Vaccines
12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
12.1 Oral Vaccines Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Oral Vaccines Major Manufacturers in 2016
12.4 Downstream Buyers
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source
LIST OF TABLES AND FIGURES
Figure Oral Vaccines Picture
Table Product Specifications of Oral Vaccines
Figure North America Sales Market Share of Oral Vaccines by Types in 2016
Table Types of Oral Vaccines
Figure Rotavir
Figure Oral Vaccines Picture
Table Product Specifications of Oral Vaccines
Figure North America Sales Market Share of Oral Vaccines by Types in 2016
Table Types of Oral Vaccines
Figure Rotavir
